Bayer Aktiengesellschaft against Teva Pharmaceutical Industries Limited — live side-by-side technical comparison.
Prices as of 2026-10-09T15:35:26+00:00 UTC · updates daily
TEVA leads 5 of the 5 windows we measure — over 1 month BAYN.DE is -11.1% and TEVA +11.5%; over year to date BAYN.DE is +18.3% and TEVA +31.7%.
| BAYN.DE | TEVA | |
|---|---|---|
| Price | $43.77 | $41.10 |
| 1 day | +2.8% | +4.7%lead |
| 5 days | -2.6% | +4.0%lead |
| 1 month | -11.1% | +11.5%lead |
| 6 months | +8.2% | +32.8%lead |
| Year to date | +18.3% | +31.7%lead |
| 52-week position | 64% of range | 96% of range |
| 52-week range | $25.78–$53.92 | $18.83–$42.02 |
| vs 50-day average | below $48.20 | above $37.62 |
| vs 200-day average | above $43.17 | above $33.91 |
| RSI (14) | 29 | 57 |
| Next earnings | 2026-11-03 | 2026-11-03 |
BAYN.DE trades at $43.77, below its 50-day average of $48.20, and above the 200-day at $43.17. It sits at 64% of its 52-week range ($25.78–$53.92); 14-day RSI is 29, in oversold territory; an average session moves it about 3.2%. For levels, the first level overhead is $45.00 (2.8% away) and the first support below is $43.17 (1.4% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
TEVA trades at $41.10, above its 50-day average of $37.62, and above the 200-day at $33.91. It sits at 96% of its 52-week range ($18.83–$42.02); 14-day RSI is 57, in neutral territory; an average session moves it about 3.0%. For levels, the first level overhead is $45.00 (9.5% away) and the first support below is $40.00 (2.7% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
BAYN.DE is the more volatile of the two — an average session moves it 3.2% against 3.0% for TEVA, so an identical position size carries roughly 1.1× the daily risk.
The comparison turns on those levels: BAYN.DE clearing $45.00 or losing $43.17; TEVA clearing $45.00 or losing $40.00. Until one of them gives way, the relative reading above stands.